| Overview |
| bs-4943R-PE-Cy7 |
| MPO Polyclonal Antibody, PE-Cy7 Conjugated |
| FCM |
| Human, Mouse, Rat |
| Dog, Pig, Horse, Rabbit, Guinea Pig |
| Specifications |
| PE-Cy7 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human MPO |
| 678-745/745 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 4353 |
| P05164 |
| Cytoplasm |
| Myeloperoxidase; MPO |
| Part of the host defense system of polymorphonuclear leukocytes. It is responsible for microbicidal activity against a wide range of organisms. In the stimulated PMN, MPO catalyzes the production of hypohalous acids, primarily hypochlorous acid in physiologic situations, and other toxic intermediates that greatly enhance PMN microbicidal activity. |
| Application Dilution |
| FCM |
1:20-100 |
Powered by Bioz